The standard for high-risk prostate cancer is supported by a study using high-dose RT and long-term ADT.

Published Date: 29 Jan 2024

Without increasing toxicity, OS, PFS, and cancer-specific survival all increased.

Read Full News

Latest News

HTTP error: 503HTTP error: 503

News All Time

HTTP error: 503 HTTP error: 503 HTTP error: 503 HTTP error: 503 HTTP error: 503 HTTP error: 503
Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

Extracellular matrix pathway emerges as treatment target for pediatric cancer

2.

Researchers explore e-bikes for cancer recovery

3.

According to new studies, some cancer patients can safely forego radiation therapy.

4.

In Hemophilia A and B, a Novel Monoclonal Antibody Reduces Bleeding.

5.

A single bout of exercise gives results that could help cancer patients


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot